Eno-Obong Essien, MD, won the $10,000 prize in the 10th annual BEAR Cage competition with her pitch, “Endothelial-Targeted mRNA-Lipid Nanoparticles; A Novel Therapeutic for Treating Acute Respiratory Distress Syndrome (ARDS)” at the ATS 2024 International Conference. Her co-finalists – Julio Huapaya, MD, MHS, and Michael Miller, MD – will each receive $2,500 for their pitches.
Medical students, residents, fellows, and junior faculty got a head start on the next stages of their respiratory health careers during the first days of the ATS 2024 International Conference. The Student Scholars Program, Resident Boot Camp, Fellows Track Symposium, and New Faculty Boot Camp welcomed more than 500 participants to San Diego for impactful…
The ATS President’s Symposium hosted a panel of lung cancer experts who reflected on the evolving understanding of the disease, celebrated advancements in care, and shared their hopes for the future.
Marc B. Schenker, MD, MPH; Denisse Rojas Marquez, MD, MPP; and Julie Linton, MD, FAAP, discussed health-related issues for immigrants in the U.S. who are faced with an ever-changing and fragmented health care system, limited access to care, and occupational hazards during Tuesday’s Keynote Series session at the ATS 2024 International Conference.
Understanding orangutan respiratory disease syndrome (ORDS) could help conservation efforts to preserve this critically endangered species, according to speakers at Tuesday’s Plenary Session at ATS 2024. Nancy Lung, VMD, MS, and Jennifer Taylor-Cousar, MD, MSCS, ATSF, discussed their collaboration to improve the management of ORDS.
With ATS 2024 Highlights: On Demand, you’ll have access to recordings of the Opening Ceremony, Plenary Session, Keynote Series, Clinical Year in Review, Adult Clinical Core Curriculum, and so much more. The topics will cover ILD, asthma, health equity, and CF, to name just a few.